Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

Delayed Quote. Delayed  - 05/27 09:59:58 pm
5.67 USD   +1.43%
05/16 OSIRIS THERAPEU : Provides Update Regarding NASDAQ Listing Matters
05/10 OSIRIS THERAPEU : to Present at the 26th European Wound Management A..
05/02 OSIRIS THERAPEU : Grafix Demonstrates Superior Clinical Outcomes Com..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
5.18(c) 5.45(c) 5.59(c) 5.59(c) 5.66(c) Last
126 069 108 277 130 207 107 713 67 204 Volume
+2.17% +5.21% +2.57% 0.00% +1.25% Change
More quotes
Financials ($)
Sales 2015 94,9 M
EBIT 2015 4,40 M
Net income 2015 2,77 M
Debt 2015 -
Yield 2015 -
Sales 2016 110 M
EBIT 2016 5,03 M
Net income 2016 4,54 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 70,88
P/E ratio 2016 45,36
Capi. / Sales 2015 2,06x
Capi. / Sales 2016 1,78x
Capitalization 195 M
More Financials
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, and tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on December... 
More about the company
Surperformance© ratings of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More Ratings
Latest news on OSIRIS THERAPEUTICS, INC.
05/27 OSIRIS THERAPEUTICS, INC. : Other Events (form 8-K)
05/16 OSIRIS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continue..
05/16 OSIRIS THERAPEUTICS : Provides Update Regarding NASDAQ Listing Matters
05/10 OSIRIS THERAPEUTICS : to Present at the 26th European Wound Management Associati..
05/02 OSIRIS THERAPEUTICS : Grafix Demonstrates Superior Clinical Outcomes Compared wi..
05/02 OSIRIS THERAPEUTICS : Grafix Demonstrates Superior Clinical Outcomes Compared wi..
04/21 OSIRIS THERAPEUTICS : to Present 15 Advanced Clinical and Scientific Abstracts
04/12 OSIRIS THERAPEUTICS : to Present 15 Advanced Clinical and Scientific Abstracts
04/12 OSIRIS THERAPEUTICS : to Present 15 Advanced Clinical and Scientific Abstracts
04/08 OSIRIS THERAPEUTICS : Announces Further Expansion of Grafix Commercial Coverage
More news
Sector news : Bio Therapeutic Drugs
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
05/27 MEDIVATION : Files Preliminary Consent Revocation Statement
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/03 MiMedx takes exception to Osiris Therapeutics' "real-world study" comparing G..
03/24 Osiris Therapeutics Beset By Newer And Bigger Troubles
03/22 Osiris deficient with Nasdaq over late 10-K
03/16 Osiris unable to file 2015 annual report due to accounting errors; shares dow..
02/05 Osiris chief exit reinforces problems at company
Advertisement
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Technical analysis trends OSIRIS THERAPEUTI...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions